The DEAD box RNA helicase, p68, is upregulated in exponentially growing cells and shows cell cycledependent changes in nuclear localization. Although some other DEAD box proteins have been implicated in cancer, there have been no reports of any link between p68 status and carcinogenesis. In the present study we have analysed specimens from 50 patients with colorectal adenocarcinomas, including cases in which an adenomatous polyp was also present, by immunohistochemistry and Western blotting. Our data indicate that p68 protein is consistently overexpressed in tumours as compared with matched normal tissue. Examination of the levels of p68 mRNA from both normal and tumour tissue showed no obvious speci®c increase in p68 mRNA levels in tumours nor any evidence of underlying mutations in the p68 coding region. Interestingly, however, the accumulated p68 appears to be poly-ubiquitylated, suggesting a possible defect in proteasome-mediated degradation in these tumours. This overexpression/ubiquitylation is observed in both pre-invasive and invasive lesions suggesting that the dysregulation of p68 expression occurs early during tumour development. Finally, we demonstrate that ubiquitylation of p68 occurs in cultured cells, thereby providing a model for the molecular analysis of this process and its potential role in tumorigenesis. Oncogene (2001) 20, 7734 ± 7743.
Introduction
The modulation of RNA secondary structure is an essential step in many key processes in the cell, such as pre-mRNA splicing, ribosome assembly and translation. The emergence of a large family of`D EAD box' RNA helicases, members of which share the highly conserved motif Asp-Glu-Ala-Asp together with several other conserved functional elements, has underscored the commitment of the cell to regulating RNA structure (Fuller-Pace, 1994) . Although DEAD box proteins have been shown to share similar biochemical functions, namely RNAdependent ATPase activity and RNA helicase activity, they play important roles in a wide range of cellular processes through interaction with speci®c RNA molecules.
The human nuclear protein p68 is a prototypic member of this family and is an established ATPase and RNA helicase (Hirling et al., 1989; Iggo and Lane, 1989) ; however little is known about its biological function. p68 protein expression has been shown to be growth and developmentally regulated, suggesting that the protein may play a role in cell proliferation (Lane and Hoeer, 1980; Stevenson et al., 1998) . Moreover, p68 exhibits marked changes in its nuclear localization during the cell cycle; in interphase p68 is largely excluded from the nucleoli but it appears to be transiently associated with nascent nucleoli in late telophase, consistent with a possible cell cycle-dependent regulation of function (Iggo et al., 1991; Nicol et al., 2000) . In vivo, however, the link between p68 and growth regulation appears to be more complex. For example, the protein exhibits marked tissue speci®c dierences in expression which do not necessarily correlate simply with proliferation (Stevenson et al., 1998) .
Other DEAD box proteins have been implicated not only in growth regulation but also in tumour development. For example, rck/p54 and DDX1 have been shown to be overexpressed in tumour cell lines (Akao et al., 1995; Godbout and Squire, 1993) while rck/p54 has also been found to be overexpressed in colorectal tumours (Nakagawa et al., 1999) . The DDX1 gene is often co-ampli®ed with MYCN and overexpressed in neuroblastoma, and appears to signify a poorer prognosis than MYCN ampli®cation alone (George et al., 1996; Godbout and Squire, 1993; Squire et al., 1995) . These examples are indicative of a relationship between several DEAD box proteins and abnormal or neoplastic cell growth, and imply that over-expression may contribute to the progression of proliferative disease.
The development and progression of colorectal neoplasia provides a useful model for the study of molecular carcinogenesis (Fearon and Vogelstein, 1990) . Colorectal adenocarcinoma is the second most common fatal form of malignancy in the Western world and tissue samples from both the established primary malignant lesions and pre-malignant adenomas are accessible and can be readily obtained for molecular analysis. Therefore, we chose colorectal tumours as a model to investigate whether p68 expression is dysregulated during carcinogenesis. In this study we show that p68 is overexpressed in colorectal adenocarcinomas and adenomatous polyps as compared with matched normal tissue. Interestingly the accumulated p68 appears to be poly-ubiquitylated, raising the possibility of a defect in proteasomemediated degradation in these tumours. The overexpression/ubiquitylation is observed in both benign and malignant lesions suggesting that the dysregulation of p68 expression occurs early during tumour development.
Results

Expression of p68 protein: immunohistochemistry
The expression of p68 was initially investigated in normal and neoplastic colorectal mucosa by immunohistochemical staining of frozen sections from paired normal and neoplastic mucosal biopsy specimens. The sections were stained with ®ve antibodies: the mouse monoclonal antibody PAb 204 and the rabbit polyclonal antibodies 2906, 2907, A2 and B1, which recognize dierent epitopes on the p68 protein (see Materials and methods). The antibody 2907 was routinely used for immunohistochemical staining; however all antibodies gave similar results (data not shown). In the normal colorectal mucosa, staining for p68 was largely con®ned to the glandular epithelial cell nuclei. However, not all the epithelial cells were positive, with unstained nuclei being clearly recognized ( Figure 1a ) and staining was not con®ned to the proliferative compartment. In contrast, the nuclei of neoplastic glands in all tumours displayed intense granular staining for p68 (Figure 1b ). In the neoplastic epithelium virtually all nuclei exhibited positive staining and, whilst dicult to assess reliably by immunohistochemistry, suggested a signi®cantly increased level of expression of p68 in the tumour cells. A proportion of in¯ammatory cells within the lamina propria also showed positive nuclear staining, but most were negative. This distribution and pattern of staining was also evident in adenomatous lesions, suggesting that these changes in p68 expression correlated with neoplastic growth in general rather than with invasive malignancy (Figure 1b,c) . The sections shown are representative of the cases examined. In one section both normal and neoplastic glands at the edge of an adenocarcinoma were represented (Figure 1d ), providing a reliable internal control for the staining technique.
As additional controls we also stained a tumour section with pre-immune serum (Figure 2a ) and compared the staining with that obtained with immune serum (Figure 2b ). As seen in this ®gure no staining was obtained when the pre-immune serum was used, indicating that the p68 staining was speci®c. Figure 2c shows a higher magni®cation of the staining obtained with the p68 antibody (2907) highlighting the granular staining in the nuclei of the epithelial cells. Several normal and tumour tissues were stained with the other p68 antibodies (see above). All gave similar staining patterns (data not shown); Figure 2d shows an example of a tumour section stained with the mouse monoclonal antibody, PAb 204. To further con®rm the speci®city of staining, another section was stained with the 2907 antibody ( Figure 2e ) and as a control, with 2907 in the presence of the p68 peptide which was used for immunization ( Figure 2f ). As shown in this ®gure, the presence of peptide largely abolished staining.
These ®ndings suggest that expression of p68 is increased in the neoplastic epithelial cells of colorectal adenomas and carcinomas. All cases demonstrated the same pattern of staining, although there was some heterogeneity throughout the tumours both in terms of the staining of the epithelium and also of the proportion of the stromal in¯ammatory cells that stained positively. There were also dierences in the degree of p68 expression between dierent patients (data not shown). However, in each case, the neoplastic tissue exhibited overexpression of p68 as compared with the paired normal tissue, both in the proportion of positive cells and in the intensity of staining (see Figure 1 ). The observation of a similar pattern of staining in both benign and malignant lesions suggests that the aberrant expression of p68 is an early feature of neoplastic transformation of the colorectal epithelium.
Expression of p68 mRNA
In order to investigate whether the overexpression of p68 protein in tumours as observed by immunohistochemical analysis re¯ects a relative increase in p68 mRNA, the levels of p68 mRNA in six pairs of matched normal and carcinoma samples were compared relative to GAPDH and b-Actin mRNA, by quantitative real-time RT ± PCR. In each case complementary DNA, generated from equal amounts of poly(A) + RNA (10 ng), was quanti®ed and compared as described in Materials and methods. Comparison of the number of molecules of p68, GAPDH and b-Actin mRNA per mg of poly(A) + RNA extracted from the groups of normal and tumour tissue, using the nonparametric Wilcoxon rank sum analysis (Figure 3 ), showed that there was no signi®cant dierence in the level of p68 mRNA between normal and tumour tissue for any of the genes tested. Therefore the increase in p68 protein expression in colorectal tumours as Oncogene p68 overexpression/ubiquitylation in colorectal tumours M Causevic et al observed by immunohistochemical analysis does not appear to be due to an increase in the levels of p68 mRNA.
Using p68-speci®c primers, we also carried out RT ± PCR on p68 mRNA from normal and tumour tissue from a representative subset of patients and analysed the cDNA sequence for the p68 coding region, to determine whether there were any underlying mutations in these patients. The results from four patients indicated that the p68 sequence appeared to be wild type in each case (data not shown).
Expression of p68 protein: Western blots
Immunohistochemical methods, as a means of assessing protein expression, are generally qualitative rather than quantitative. Therefore in order to obtain a quantitative comparison, we examined the expression of p68 protein in colorectal tumours and matched normal tissues by Western blotting. Equal amounts of protein (100 mg) were analysed by SDS ± PAGE and Western blotting using p68-and b-Actin-speci®c antibodies as described in Materials and methods. Figure 4 shows the Western blotting results for a subset of patients, in each case with matched normal and tumour tissue. These are representative of the dierent types of p68 expression pattern obtained in the 50 cases examined.
In the majority of cases there was one predominant p68 species in normal tissue. This species had an apparent mobility on SDS ± PAGE consistent with a molecular weight of approximately 65 kD, as opposed to that found in cell lines, which has an apparent molecular weight of 68 kD, as seen from the HeLa cell lysate control lane (Figure 4 ). p68 from a range of cell lines migrates similarly in SDS ± PAGE (our unpublished observations). In contrast, the p68 in tumour tissue appeared to migrate aberrantly on SDS ± PAGE and multiple protein bands with a slower electrophoretic mobility were observed (Figure 4 ). In addition showed some variation between patients but no increase in the tumour tissue. Surprisingly, the 65 kD (normal size) p68 protein was absent in the tumour tissue and was replaced by three major protein species with a slower mobility in virtually all cases: (i) a 68 kD species with a mobility similar to that seen in HeLa and other cell lines; (ii) a doublet of 75 ± 80 kD; (iii) a 150 kD species, often with a`ladder' of bands up to that size. The pattern of expression showed some variation in dierent patients both in terms of the actual amount of p68 and in the proportions of the dierent p68 species present. One case, patient 1, showed a considerable amount of the 65 kD species of p68 in the tumour sample. Interestingly when we studied the immunohistochemistry of the normal and tumour sections from this patient, we observed that in the section from the tumour there was a considerable amount of normal tissue surrounding the tumour areas (data not shown). Therefore, although we cannot rule out the possibility that this tumour did indeed contain a high amount of (65 kD) p68, it is likely that the tumour tissue used to make protein lysate was in fact contaminated with normal tissue. In some patients, (patient 3 is shown as an example) a low amount of protein of 68 kD was visible in the normal tissue, while the 65 kD species was absent. In several patients (e.g. patients 1 and 5) there was a low level of the 150 kD species in the normal tissue. However, generally, the proportion of this species increases in the tumour although in a few cases (less than 10%; e.g. patient 5) the 75 ± 80 kD doublet is the predominant species. In Figure 2 Immunohistochemical staining of colorectal carcinoma tissue sections to detect p68 expression. Nuclei were counterstained with haematoxylin (blue) and p68 protein expression is shown as brown staining. Sections were stained with the following antibodies: (a) pre-immune serum for antibody 2907; (b) 2907; (c) 2907 (detail); (d) PAb 204 (tissue matched with b); (e) 2907; (f) 2907 plus competing peptide (tissue matched with e). All images were captured at 620 objective magni®cation except for c which was captured at 640 objective to show better detail of the granular nuclear p68 staining
Oncogene p68 overexpression/ubiquitylation in colorectal tumours M Causevic et al addition, for most samples investigated the extent of laddering' is increased in the tumour relative to the normal tissue. Perhaps most interesting is the ®nding that the appearance of p68 species with altered electrophoretic mobilities in tumour tissue generally correlates with the reduction or disappearance of the 65 kD (normal size) p68 species. This suggests that p68 is present predominantly in a post-translationally modi®ed state in tumours. All our p68 antibodies gave similar results in immunohistochemistry (Figure 2 and data not shown). Therefore we wished to test whether the predominant 150 kD species would also be obtained in Western blotting with other p68-speci®c antibodies. Antibody 2906, which was raised against the same epitope of p68 (amino acids 600 ± 614) as 2907 (the antibody routinely used in Western blotting) gave similar results (data not shown). We also tested the rabbit polyclonal antibody A2, which was raised against a dierent epitope of p68 (amino acids 39 ± 57). As shown in Figure 5 , although A2 works rather poorly in Western, giving a considerably weaker signal, the 150 kD band is still clearly visible, suggesting that it is p68-speci®c. Unfortunately antibodies B1 and PAb 204 are not suitable for Western blotting (our unpublished observations) and were therefore not tested.
In addition, in order to investigate whether the apparent changes in post-translational modi®cation of p68 (see Figure 4) were an early event in tumour progression, we also examined tissues from 10 adenomas and from two cases for which normal, adenoma and carcinoma tissue was available. Figure 6 shows representative examples. Most adenomas contained the 68 kD and the 150 kD species of p68 as seen for patients 6 and 7 and in all cases the 65 kD species of p68 was largely absent. For patient 6 some normal tissue was available; this showed a low level of`normal' 65 kD p68. In one case (patient 8) for which normal, adenoma and carcinoma tissue was available, there was a signi®cant amount of the 150 kD species in the normal tissue and a very large amount of the 150 kD species in the adenoma with a`ladder' of protein bands up to this size ( Figure 6 ). Interestingly, in this case, both the 65 and 68 kD species were present in the adenoma, as well as the very pronounced ladder of protein bands up to 150 kD in size, while in the carcinoma the 68, 75 ± 80 and 150 kD species are predominant. This suggest that there may be a gradual loss of the`normal' 65 kD species during progression from benign to malignant lesions. 
p68-ubiquitin conjugation in colorectal tumours
In order to identify the nature of the apparent p68 modi®cation in colorectal tumours, p68 from normal and tumour tissues, as well as from HeLa cells, was immunoprecipitated with a p68-speci®c antibody (2906) and subjected to Western blot analysis with antibodies against possible p68 modi®ers. We were particularly interested in investigating SUMO and ubiquitin modi®cations, since these often result in a large shift in electrophoretic mobility and could explain the multiple bands obtained as well as the 150 kD p68 species. The ®rst candidate modi®er tested was SUMO-1 since modi®cation by SUMO does not target proteins for degradation but, instead, often alters the subcellular localization of the modi®ed protein by modulating its ability to interact with other cellular factors (Mahajan et al., 1997; Matunis et al., 1998; Muller et al., 1998) . However, to date, attempts to detect SUMO-1 modi®cation of p68 in these tumours have not proved successful (data not shown). Ubiquitylation of proteins normally targets proteins for degradation via the 26S proteasome (reviewed in Ciechanover et al., 2000) and therefore a ubiquitylated protein would not be expected to accumulate in the cell. Nevertheless it was important to investigate whether the accumulated p68 which migrated aberrantly on SDS ± PAGE was in fact ubiquitylated. p68 was immunoprecipitated from HeLa cells and tissue lysates, Western blotted and probed with p68 and ubiquitin antibodies respectively. As shown in Figure  7a ,c, although immunoprecipitation of p68 from tissues was generally less ecient than from HeLa cells, the p68 species found in tumours could be immunoprecipitated. It was dicult to detect the 65 kD species in normal tissue (Figure 7a ). This may be partly due to the lower eciency of immunoprecipitation but is also complicated by the unavoidable cross-reaction of the secondary antibodies to the heavy chain of the immunoprecipitating antibody. When the Western blots were probed with the anti-ubiquitin antibody (Figure 7b,d ) the 150 kD p68 species was strongly detected, suggesting that this represents a ubiquitylated form of p68. The very faint signal obtained for the 68 kD species in HeLa cells (Figure 7b,d ) could possibly represent a mono-ubiquitylated form of a small minority of the p68 molecules (the signal obtained for this p68 species by probing with the p68 antibody (Figure 7a,c) is considerably stronger).
Alternatively it may be due to some minor non-speci®c cross-reaction. No signal was obtained with the 75 ± 80 kD doublet, suggesting that either these species represent a dierent modi®cation or that the ubiquitin epitopes in these species are in some way masked. Preliminary studies to identify potential modi®cations of these p68 species have so far not provided any evidence of phosphorylation and/or glycosylation (data not shown).
Ubiquitylation of p68 in cell lines
Standard Western blot analysis of p68 from a variety of cell lines generally shows one protein species with an apparent molecular weight of 68 kD (our unpublished observations). We therefore wished to examine whether p68 can be poly-ubiquitylated in cells lines; this would act as a further con®rmation of the immunoprecipitation/Western results discussed above. For these experiments COS-7 cells were co-transfected with plasmids encoding myc-tagged p68 and His-tagged ubiquitin. After treating with the proteasome inhibitor, ALLN, the His-tagged ubiquitin was puri®ed on nickel agarose beads and after elution, ubiquitylated p68 was identi®ed by Western blotting using p68-speci®c (2907) and anti-myc epitope (9E10) antibodies. Figure  8 shows the results from such an experiment. As shown in Figure 8a , blotting with an antibody against the myc epitope (which detects the transfected, myc-tagged, p68) revealed multiple forms of p68 only when the cells were co-transfected with both p68 and ubiquitin. This was con®rmed as p68 by blotting with the p68-speci®c antibody (Figure 8b ) which also showed that, as expected, the multiple ubiquitylated forms of p68 have a slower electrophoretic mobility than the endogenous p68.
Discussion
We have shown that the DEAD box RNA helicase, p68, is overexpressed and post-translationally modi®ed in both benign and malignant colorectal tumours. Immunohistochemical examination of normal and tumour tissue showed an increase in p68 expression both in terms of the proportion of epithelial cells staining positively and in the apparent intensity of staining in the nuclei of positive cells (Figure 1) . Examination of the levels of p68 mRNA in normal and tumour tissue showed no speci®c increase in p68 . Western blot analysis of protein lysates from normal and tumour tissues showed that, in the tumours, multiple species of p68 are present which have an apparently slower electrophoretic mobility in SDS ± PAGE (Figure 4 ). This is consistent with p68 being post-translationally modi®ed in tumours. Interestingly, the appearance of these modi®ed forms generally correlates with the disappearance of thè normal' p68 species. Moreover the multiple p68 species are also evident in adenomas ( Figure 6 ) con®rming that the changes in p68 expression/modi®cation are an early event in tumour development and are associated with the development of neoplastic cells rather than invasive malignancy. Examination of the multiple p68 species by immunoprecipitation/Western blotting indicated that the 150 kD species represents a ubiquitylated form of p68 (Figure 7 ). This observation is of particular interest since the marking of proteins with ubiquitin normally targets them for degradation by the 26S proteasome. There could be several reasons for this phenomenon. (A) The high levels of p68 expression may result in aggregation of these proteins, which may cause à bottleneck' for degradation or may simply not be degraded eciently. The 26S proteasome is relatively inecient in degrading aggregated proteins and aggregates of ubiquitylated proteins can accumulate in cells (Kopito and Sitia, 2000) . Examples include the intranuclear inclusions observed in Huntington's disease (Davies et al., 1997) and Spinocerebral Ataxia (Cummings et al., 1998) . (B) There may be some defect in the 26S proteasome system in colorectal tumours; this may be speci®c to p68 or may be more general. The concept of defects in ubiquitin-mediated degradation in tumours is of interest in the light of recent reports showing that wild type c-Myc, which is normally ubiquitylated and degraded by the 26S proteasome, is stabilized in Burkitt's Lymphoma cells (Gregory and Hann, 2000) and that the proteasome itself is functionally impaired in these cells (Gavioli et al., 2001 ). (C) It is also possible that ubiquitylation of p68 is more ecient in colorectal tumours which, in combination with defects in the degradation pathway or protein aggregation, could give rise to the very high levels of ubiquitylated p68 observed. Increases in the eciency of ubiquitylation could arise from (a) some other post-translational modi®cation of p68 which favours ubiquitylation, (b) an increase in the activity of the relevant E3 ligase, or (c) defects in deubiquitylating enzymes.
In recent years, work from several laboratories has highlighted the fact that ubiquitin-mediated degradation of proteins is highly regulated and plays a key role in a wide range of cellular processes (reviewed in Ciechanover, 1998; Ciechanover et al., 2000; Desterro et al., 2000) . Changes in ubiquitylation and degradation of speci®c proteins have been implicated in a range of diseases. For example, the tumour suppressor p53 is targeted for ubiquitin-mediated degradation by its association with the E6 protein of high-risk strains of human papilloma virus (Schener et al., 1993) . However, although ubiquitylation generally leads to protein degradation, it can also have roles other than direct proteolysis (reviewed in Hochstrasser, 1996) . For example, the ribosomal protein L28 (Spence et al., 2000) is ubiquitylated, in a cell cycle-regulated manner, by a variant multi-ubiquitin chain which does not appear to target it for degradation; this modi®cation is required for proper functioning of the translational apparatus.
Another key issue may underlie the disappearance of the`normal' p68 species in tumours with the transition to the modi®ed species being evident in adenomas (Figures 4 and 6) . At present the nature of possible modi®cations that would result in the 68, and 75 ± 80 kD species is not known. Such modi®cations could, Figure 7 Western blots of p68 immunoprecipitated from normal and carcinoma tissues as well as HeLa cells, using the p68-speci®c antibody 2906. A Hela cell lysate (HeLa Lys.) is included as a control. Two sets of immunoprecipitations were carried out (shown in a/b and c/d respectively) and then probed sequentially with the p68-speci®c antibody, 2907 (a and c) and an anti-ubiquitin antibody (b and d). Arrowheads, to the right of the ®gure, indicate the dierent p68 protein species found in normal, adenoma and carcinoma tissue, together with their approximate predicted molecular weights (in kilodaltons). Molecular weight markers are shown on the left. Cross-reaction between the antibody heavy chains (HC) is indicated. IP-immunoprecipitated proteins; H-HeLa cell lysate; Nnormal tissue; C-carcinoma tissue p68 overexpression/ubiquitylation in colorectal tumours M Causevic et al in turn, aect ubiquitylation (reviewed in Ciechanover, 1998) . Moreover, the p68 protein in normal colorectal tissue (65 kD) appears to be smaller than that found in cell lines (68 kD) (see Figures 4 and 6) . It is unclear whether this is due to modi®cation or cleavage of the p68 protein in normal tissue. In vitro translated p68 protein has an apparent molecular weight of 68 kD, equivalent to that from cell lines and no 65 kD cleavage product is observed (data not shown). This will require further investigation. It will also be important to determine whether the ubiquitylated form(s) of p68 represents a functional protein, or possibly a protein with an altered function, perhaps brought about by changes in nuclear localization. It was not possible to determine precise subnuclear localization by standard immunohistochemistry of tumour sections (Figures 1 and 2) ; more extensive immuno¯uorescence microscopy will clearly facilitate such investigations. In this respect, the use of our tissue culture cell model for the study of p68 ubiquitylation will allow us to undertake a detailed molecular study of this process and its eect of p68 function. This will be important since further molecular analysis of p68 ubiquitylation in patient samples is dicult due to the limited amount of material available.
The results of the present study clearly indicate that increased expression of p68 and the presence of posttranslationally modi®ed forms, together with loss of the normal p68, are early events in the development of colorectal neoplasms. If they are not implicated directly in the process of cellular transformation, it is possible that they facilitate expansion of the neoplastic cell population. Even if over-expression/modi®cation of p68 is simply a`symptom' of other cellular changes associated with the early stages of tumour development these biochemical abnormalities could be a useful diagnostic marker for neoplastic changes in the colorectal epithelium. This may be of value in the surveillance of patients with underlying diseases that are known risk factors for the development of colorectal adenocarcinoma, such as ulcerative colitis. In these cases recognition of dysplasia is often confounded by co-existent in¯ammatory disease; therefore an objective parameter by which dysplasia could be reliably de®ned would be of particular value.
Materials and methods
Human tissue origin and storage
Specimens from 50 patients with colorectal adenocarcinomas, including two cases in which a synchronous adenomatous polyp was also present, together with 10 other adenomas, were made available from the Ninewells Hospital Tissue Bank, where they were stored at 7808C. In each case paired normal tissue was obtained from macroscopically unremarkable mucosa distant from the tumour or any other mucosal lesion. All samples were taken from surgical resection specimens which were examined by a pathologist to con®rm diagnosis and were obtained with informed consent from patients undergoing surgery. All procedures were carried out according to local Ethical Committee guidelines.
Antibodies p68
Rabbit polyclonal antibodies 2906/2907 (Stevenson et al., 1998) , A2 and B1 and mouse monoclonal antibody PAb 204 were used in this study.
2906 and 2907 were generated against the C-terminal 15 amino acids of p68 (amino acids 600 ± 614). Both give similar results in immunohistochemistry and Western blotting; however 2906 was found to give slightly less background in immunoprecipitations and 2907 gave slightly cleaner Western blots. A2 and B1 were raised against amino acids 39 ± 57 and 61 ± 69 respectively in p68 and gave identical staining patterns in immunohistochemistry. Proteins were puri®ed on nickel agarose beads to isolate species that are conjugated to His-tagged ubiquitin. Eluted proteins were separated on SDS ± PAGE and probed sequentially with the antimyc epitope antibody, (9E10 -a) to detect the transfected myctagged p68 and then with the p68-speci®c antibody (2907 -b) to detect both ectopically-expressed and endogenous p68. A COS-7 cell lysate (COS Lys.) was included as a control. Molecular weight markers are shown on the left. Mock-untransfected cells; p68+Ub-cells co-transfected with p68 and ubiquitin plasmids; p68-cells transfected with the p68 plasmid only; Ub-cells transfected with the ubiquitin plasmid only Oncogene p68 overexpression/ubiquitylation in colorectal tumours M Causevic et al PAb 204 was originally generated against the SV40 Large T antigen but it cross-reacts with p68 (amino acids 506 ± 523) (Ford et al., 1988; Lane and Hoeer, 1980) . It is speci®c for p68 in cells that are not infected or transformed by SV40.
b-Actin: commercial rabbit polyclonal antibody (A-2066) from Sigma.
Ubiquitin: commercial rabbit polyclonal antibody (U-5379) from Sigma.
Myc epitope: mouse monoclonal antibody (9E10) which recognizes proteins tagged with the myc epitope (MRQKLI-SEEDL) (Evan et al., 1985) .
Plasmids p68
A full length p68 cDNA, myc-tagged at the N-terminus was cloned in the pSG5 vector (Stratagene) and expressed under the control of the SV40 early promoter.
Ubiquitin This plasmid contained eight copies of the ubiquitin precursor, in each case His-tagged at the Nterminus and under the control of the CMV promoter. This is described in (Treier et al., 1994) and was a gift from Dr S Mittnacht.
Cell lines
HeLa cells were routinely used to prepare control lysates for Western blotting. COS-7 cells were used for transfection with p68 and ubiquitin plasmids.
Immunohistochemical staining
For the immunohistochemical study, 5 mm-thick cryosections of human colorectal tissues were ®xed in acetone and unless otherwise stated, p68 was detected using rabbit polyclonal anti-p68 antibody, 2907 in Tris-buered saline (TBS: 50 mM Tris-HCl, pH 7.6, 150 mM NaCl). Endogenous peroxidase enzyme activity was blocked with 0.6% hydrogen peroxide in methanol and background staining was blocked by incubating sections in a 1 : 20 dilution of the relevant secondary antibody, in TBS, prior to incubating with the primary (antip68) antibody. Bound antibody was detected by the ABComplex biotin/streptavidin ampli®cation system (DAKO), according to manufacturer's instructions. Nuclei were counter-stained with haematoxylin (Sigma). Sections treated with either pre-immune serum or TBS alone acted as negative controls in each case. Images of sections were obtained using a Zeiss Axioplan 2 robotic microscope and Autocyte Link imaging software.
Real-time polymerase chain reaction quantification
Complementary DNA generated from 10 ng of RNA was quanti®ed in real-time PCR using Sybr Green I dye as the detection system. Reactions were carried out using a Light Cycler PCR machine (model LC24: Biogene Ltd, Kimbolton, Cambridgeshire, UK). Concentrations of b-Actin, GAPDH and p68 (molecules/mg poly(A) + RNA) were derived from standard curves generated from plasmids containing the relevant cloned cDNA sequences. Amplicon melt analysis and electrophoresis on agarose gels were used to con®rm the ®delity of ampli®cation. Groups of results were compared using the non-parametric Wilcoxon rank sum analysis. P values 50.05 were considered to be signi®cant. The following primers were used. p68: 5'-AGAGGTTCAGGTCGTTC-CAGG-3' and 5'-GGAATATCCTGTTGGCATTGG-3' (amplicon 408 bp); GAPDH: 5'-GGTGAAGGTCGGAGTC-AACGG-3' and 5'-GAGGGATCTCGCTCCTGGAAG-3' (amplicon 240 bp); b-Actin: 5'-TGTTTGAGACCTTCAA-CACC-3' and 5'-TTCATGAGGTACTCAGTCAG-3' (amplicon 205 bp).
Preparation of protein from cells/tissues and Western blotting
Tissue culture cells were lysed in SDS sample buer (5% SDS, 0.15 M Tris pH 6.7, 30% glycerol) diluted 1 : 3 in RIPA buer (25 mM Tris pH 8.0, 150 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate (DOC), 0.1% SDS) containing 10 mM iodoacetamide and complete protease inhibitor cocktail (Boehringer Mannheim). Lysates were sonicated brie¯y and cleared by centrifugation at 14 000 g for 5 min.
Tissue samples were ground into powder with pestle and mortar under liquid nitrogen prior to homogenization in buer containing 26PBS, 0.1% SDS, 1% IGEPAL, 0.5% DOC, 1 mM DTT, 1 mM EDTA, 10 mM NaF, 0.2 mg/ml RNase A, with complete protease inhibitor cocktail (Boehringer Mannheim). Lysates were brie¯y sonicated, left on ice for 15 min and then centrifuged for 5 min at 14 000 g to remove debris. For each sample, 100 mg of protein were separated by standard SDS ± PAGE using a 7.5% gel (Acrylamide:Bis-acrylamide ratio of 30 : 0.5). This approach achieved optimal separation of p68 species, which are masked in standard gels due to the high abundance of another cellular protein with an apparent molecular weight of approximately 65 kD.
Proteins were electroblotted onto a nitrocellulose membrane (0.2 mm pore size, Protran Schleicher and Schuell) and p68 and b-Actin were detected by standard immunoblotting conditions (Harlow and Lane, 1988) using rabbit polyclonal antibodies, 2907 and U-5379 respectively, and visualized by the Amersham ECL method. Under the gel conditions used (see above) to optimize separation of p68 species, b-Actin (42 kD) was not visible; therefore the same amounts of protein lysates were also loaded on a separate 10% gel (Acrylamide:Bis-acrylamide ratio of 30 : 0.5) and probed for b-Actin as a loading control.
Immunoprecipitation
Tissue lysates were prepared as for Western blotting. Immunoprecipitation (IP) reactions contained 100 mg protein lysate, 5 ml of polyclonal antibody, 2906, in a total volume of 500 ml of IP buer (150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 0.5% IGEPAL, 10 mM NaF, 10 mM b-mercaptoethanol, complete protease inhibitor cocktail (Boehringer Mannheim) and 50 ml of Protein A Sepharose beads (Pharmacia)). Immunoprecipitated proteins were separated by SDS ± PAGE and Western blotted as described above. For immunoblotting of the same membrane with dierent antibodies, bound antibody was removed by incubating the membrane in 50 mM Tris-HCl, pH 6.8, 2% SDS, 100 mM b-mercaptoethanol for 15 min at 708C, followed by extensive washes in PBS-T (0.1% Tween 20 in PBS).
Cell culture and transfection
HeLa cells and COS-7 cells were grown in Dulbecco's Modi®ed Eagle's Medium supplemented with 10% foetal calf serum, 2 mM glutamine, 100 IU/ml penicillin and 100 mg/ml streptomycin (Life Technologies) in 5% CO 2 . Cells were seeded at 1610 6 per 10 cm plate 4 h prior to transfection, using the Calcium phosphate precipitation method described by Webster and Perkins (1999) . Forty hours later, the proteasome inhibitor N-Acetyl-Leu-Leu-Norleucinal (ALLN) was added at a ®nal p68 overexpression/ubiquitylation in colorectal tumours M Causevic et al concentration of 100 mg/ml and cells were incubated for a further 6 h prior to extraction of protein.
Purification of His 6 -tagged ubiquitin conjugates
Puri®cation of His 6 -tagged ubiquitin and bound proteins was performed as described by Rodriguez et al. (1999) 46 h after transfection (6 h after addition of ALLN). Ubiquitylated p68 was detected by Western blotting using the p68-speci®c antibody 2907.
